Dr Gaudet is the Scientific Director of the UdeM Community Genetic Medicine Center and its Clinical Lipidology and Rare Lipid Disorders Unit. He is currently President and Scientific Director of ECOGENE-21, a not-for-profit organization devoted to access to innovation in precision medicine. His main clinical and academic activities aim at investigating rare dyslipidaemias and translating new knowledge from extreme phenotypes to more common forms of diseases. He has coordinated more than 200 studies involving the development of screening tools, technologies or therapies for severe dyslipidaemias or related disorders in collaboration with biotech, pharmaceutical or academic partners. He has authored more than 300 scientific publications in peer-reviewed journals, including many in highly rated journals (NEJM, Lancet, Nature Medicine, Nature Genetics), and more than 500 scientific communications or book chapters.